Dow under pressure, Nasdaq climbs as U.S. pauses Johnson & Johnson COVID vaccine rollout

U.S. stocks trade mixed Tuesday after U.S. public-health agencies request a temporary halt in the use of Johnson & Johnson’s one-shot COVID vaccine out of “an abundance of caution” due to extremely rare blood-clotting issues in women.